The healthcare industry has the potential to save billions of dollars thanks to the introduction of new technology, as outlined by industry experts during the second day of CPhI Middle East & Africa, concluding today at the Abu Dhabi National Exhibition Centre (ADNEC). 

During the session Malek El Husseini, Healthcare Partner, Sustainable City outlined the cost saving potential of remote patient monitoring, which enables monitoring out with the conventional clinical settings (US$200+ billion saving); telehealth, the distribution of health-related services and information via electronic information and telecommunication technologies (US$100+ billion); and behaviour modification, the cost saving of which are indefinitely. 

Speaking at the event, Mr Husseini, said: “When it comes to cost savings digitalisation is allowing patients to take greater responsibility for active management of some of their own health issues and professionals to detect risks earlier - ultimately reducing the burden of diseases. 

“Digital health can also ensure available health resources are used most effectively and where and when needed,” he added. 

During the presentation Husseini outlined the breakthroughs in technology reshaping the medical landscape, these include: 

  • 3D printing: Researchers hope to expand its use to develop increasingly complex organs and replace body parts
  • Stem Cell: Advances will lead to more effective treatments fro heart disease, cancer brain disorders and other conditions
  • Machines learning and AI: advances will enable clinicians to use algorithms to analyse patients’ health, diagnose problems and more,
  • Wearables: Soon will be common for consumers to wear technology that captures vital signs data and monitors their health 24-hours-a-day
  • Robotic Surgery: Anew generation of robots will perform procedures with enhanced accuracy and precision. 

“Sustainable health is about promoting wellbeing, delivering connected and better healthcare and pursuing innovation. We are deemed to change,” added Husseini. 

CPhI Middle East and Africa, which was officially opened by His Excellency Sheikh Nahyan bin Mubarak al Nahyan, Minister of Tolerance, will end today, Wednesday 5th September. The event is providing a showcase for over 250 exhibitors and is expected to attract more than 4,000 pharma professionals from around the world.

-Ends- 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia and the Middle East, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: www.cphi.com 

The UBM annual schedule of Pharmaceutical events includes: CPhI, ICSE, P-MEC, BioPh and InnoPack Japan (18-20 April, 2018 at the Big Sight Exhibition Centre – Tokyo, Japan); CPhI, ICSE, FDF and InnoPack North America (24-26 April, 2018 at the Pennsylvania Convention Center – Philadelphia, USA); CPhI and P-MEC China (20 – 22 June, 2018 at SNIEC – Shanghai, China); CPhI Korea (28-30 August 2018, COEX, Seoul, Korea); CPhI Middle East & Africa (3-5 September, 2018 at the ADNEC – Abu Dhabi, United Arab Emirates). BioLIVE (9-11, October, 2018 in Madrid); CPhI, ICSE, P-MEC, FDF and InnoPack Worldwide (9-11 October, 2018 at the IFEMA, Feria de Madrid – Madrid, Spain); CPhI & P-MEC India (3–6 December 2018 at the BEC and BKC Exhibition and Convention Centres – Mumbai, India); Pharmapack Europe (6-7 February, 2019 at the Paris Expo, Porte de Versailles – Paris, France); CPhI, P-MEC, ICSE, Labworld and Innopack South East Asia (6-8 March, 2018 at BITEC - hall 99 – Bangkok, Thailand).

About UBM (and parent company Informa)

CPhI is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world.

To learn more and for the latest news and information, visit www.ubm.com and www.informa.com  

Media contact 

JAMES LAKIE

General Manager

Tel: +971 4 365 2711 | Mobile: +971 50 153 6544

E-mail: james.lakie@shamalcomms.com 

Office 106, Arjaan Office Tower, Dubai Media City

PO Box 502701 | Dubai, United Arab Emirates

Website: www.shamalcomms.com 

© Press Release 2018

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.